Akum Drugs Gets CDSCO Panel Nod To Conduct Post Marketing Surveillance study of Linezolid Sustained Release Tablets Dr. Divya Colin8 April 2025 5:45 PM ISTNew Delhi: Akums Drugs and Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Akum Drugs & Pharmaceutical gets CDSCO Panel nod for BE study of FDC Eplerenone plus Torsemide film-coated tablet Dr. Divya Colin8 Dec 2024 5:45 PM ISTNew Delhi: Akum Drugs and Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
NPPA Fixes Retail Price Of 37 Formulations, Details Dr. Divya Colin24 May 2024 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of the 37 formulations under the...
No safety data available, Conduct Phase-III CT: CDSCO Panel Tells Akums on Norethindrone, Estradiol, Relugolix film-coated tablet Dr. Divya Colin12 Jan 2024 6:00 PM ISTNew Delhi: Citing that there is no safety and efficacy data, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
NPPA fixes Retail Prices of 19 Formulations, Details Susmita Roy6 Jan 2024 6:00 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, Government...
Revise BE study protocol: CDSCO Panel tells Akum Pharma on FDC of Chlorthalidone, Cilnidipine, Bisoprolol film-coated tablet Dr. Divya Colin29 Dec 2023 5:00 PM ISTNew Delhi: Citing that individual and innovators' products should be taken as a reference product in the proposed bioequivalence study protocol, the...
Revise BE study Protocol: CDSCO Panel Tells Akum Pharma on Chlorthalidone, Cilnidipine, Bisoprolol FDC Dr. Divya Colin24 Dec 2023 6:00 PM ISTNew Delhi: Citing that individual and innovators products should be taken as a reference product in the proposed bioequivalence (BE) study protocol,...
Modify phase III clinical trial protocol: CDSCO panel tells Akum Pharma on antidiabetic FDCÂ Dr. Divya Colin17 Dec 2023 5:30 PM ISTNew Delhi: Approving to conduct the bioequivalence (BE) study of the antidiabetic drug combination Repaglinide plus Voglibose plus Metformin...
Conduct Phase III CT: CDSCO Panel Tells Akum Pharmaceutical on Antidiabetic FDC Dr. Divya Colin10 Dec 2023 6:00 PM ISTNew Delhi: Rejecting the proposal for the clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Modify phase IV CT Protocol: CDSCO panel Tells Akums Pharma on FDC Bempedoic acid, Rosuvastatin Calcium Dr. Divya Colin26 Nov 2023 5:45 PM ISTNew Delhi: After reviewing the Phase IV clinical trial protocol of the fixed-dose combination Bempedoic acid plus Rosuvastatin Calcium presented by...
Akums Pharma gets CDSCO panel nod To Manufacture, Market FDC of doxylamine and pyridoxine Dr. Divya Colin14 Nov 2023 6:00 PM ISTNew Delhi: The drug major Akum Drugs and Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug...
NPPA fixes retail price of 29 formulations, details Dr. Divya Colin30 Oct 2023 4:30 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
